— Know what they know.
Not Investment Advice

AXIM OTC

AXIM Biotechnologies, Inc.
1W: -6.1% 1M: -7.6% 3M: -19.1% YTD: -70.4% 1Y: -38.2% 3Y: -85.2% 5Y: -99.4%
$0.00
-0.00 (-2.86%)
 
Weekly Expected Move ±16.2%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $1.2M mcap · 244M float · 0.143% daily turnover · Short 74% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-08-04
Earliest Filing
2022-09-19
Latest Filing
partner: 1 target: 1

Counterparties (Filed by AXIM)

2 relationships

Companies named in AXIM's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Verséa Ophthalmics, LLC — partner Entered into a five-year License and Distribution Agreement for global sale and distribution of AXIM's ocular diagnostic 2022-09-19 View
Advanced Tear Diagnostics, LLC — target Acquisition of Eye Care technology and assets in exchange for 7,000,000 restricted shares of common stock. 2021-08-04 View
Recent 8-K Filings (11)
Filing Date Description Type SEC
2024-10-15 Changes in Control of Registrant; Departure/Election of Directors; Appointment of Officers View
2024-03-21 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme Agreement View
2023-06-02 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2023-05-25 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2022-09-19 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2022-03-09 Termination of Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exh View
2022-02-16 Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of Agreement View
2022-01-12 Departure/Election of Directors; Appointment of Officers View
2022-01-07 Departure/Election of Directors; Appointment of Officers View
2021-08-04 Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit Agreement View
2021-05-14 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms